• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

倍他米松-17-戊酸酯在半固体制剂基质中的稳定性

The stability of betamethasone-17-valerate in semi-solid bases.

作者信息

Yip Y W, Po L W

出版信息

J Pharm Pharmacol. 1979 Jun;31(6):400-2. doi: 10.1111/j.2042-7158.1979.tb13532.x.

DOI:10.1111/j.2042-7158.1979.tb13532.x
PMID:39141
Abstract

The stability of betamethasone-17-valerate in semi-solid bases has been investigated. Emphasis has been placed on the stability problems which could arise upon dilution of proprietary preparations by the use of model systems. Betamethasone-17-valerate has been shown to decompose to betamethasone-21-valerate and betamethasone alcohol. Quantitation of the decomposition was by direct densitometry on thin layer chromatographic plates. The decomposition was found to be an apparent first order process and to depend on the diluent used and its concentration. Attempts were also made to relate the rate of decomposition to the pH of the base used, and to stabilize the products.

摘要

已对倍他米松-17-戊酸酯在半固体制剂基质中的稳定性进行了研究。重点关注了使用模型系统稀释市售制剂时可能出现的稳定性问题。已证明倍他米松-17-戊酸酯会分解为倍他米松-21-戊酸酯和倍他米松醇。通过薄层色谱板上的直接光密度测定法定量分解情况。发现分解是一个表观一级过程,且取决于所用稀释剂及其浓度。还尝试将分解速率与所用基质的pH值相关联,并使产品稳定化。

相似文献

1
The stability of betamethasone-17-valerate in semi-solid bases.倍他米松-17-戊酸酯在半固体制剂基质中的稳定性
J Pharm Pharmacol. 1979 Jun;31(6):400-2. doi: 10.1111/j.2042-7158.1979.tb13532.x.
2
High-performance liquid chromatographic assay of betamethasone 17-valerate and its degradation products.
J Chromatogr. 1979 Sep 1;176(3):399-405. doi: 10.1016/s0021-9673(00)89458-3.
3
The stability and blanching efficacy of betamethasone-17-valerate in emulsifying ointment.
Br J Dermatol. 1982 Jul;107(1):71-6. doi: 10.1111/j.1365-2133.1982.tb00292.x.
4
The stability and blanching efficiency of some Betnelan-V cream dilutions.
J Clin Hosp Pharm. 1986 Apr;11(2):101-6. doi: 10.1111/j.1365-2710.1986.tb00833.x.
5
The effect of serial dilution of betamethasone-17-valerate on blanching potential and chemical stability.
J Clin Hosp Pharm. 1983 Jun;8(2):143-5. doi: 10.1111/j.1365-2710.1983.tb01044.x.
6
Release of betamethasone 17-valerate from extemporaneous dilutions of a proprietary topical cream.从一种专利外用乳膏的临时稀释液中释放倍他米松 17-戊酸酯。
Dermatologica. 1981;163(4):331-7. doi: 10.1159/000250181.
7
In vitro diffusion cell design and validation. I. A stability-indicating high-performance liquid chromatographic assay for betamethasone 17-valerate in purified isopropyl myristate receptor phase.体外扩散池的设计与验证。I. 纯化肉豆蔻酸异丙酯受体相中戊酸倍他米松的稳定性指示高效液相色谱法测定。
Pharm Res. 1989 May;6(5):431-5. doi: 10.1023/a:1015995818613.
8
Formulation factors affecting the isomerization rate of betamethasone-17-valerate in a developmental hydrophilic cream - a HPLC and microscopy based stability study.影响倍他米松-17-戊酸酯在一种新型亲水性乳膏中异构化速率的制剂因素——基于高效液相色谱法和显微镜的稳定性研究
Pharm Dev Technol. 2017 Jun;22(4):537-544. doi: 10.3109/10837450.2016.1143003. Epub 2016 Feb 19.
9
Simultaneous Determination of Cinchocaine Hydrochloride and Betamethasone Valerate in Presence of Their Degradation Products.在存在降解产物的情况下同时测定盐酸辛可卡因和戊酸倍他米松。
J Chromatogr Sci. 2017 May 1;55(5):518-527. doi: 10.1093/chromsci/bmx004.
10
The stability and blanching efficiency of betamethasone-17-valerate in emulsifying ointment.倍他米松-17-戊酸酯在乳化软膏中的稳定性及漂白效率
Br J Dermatol. 1983 Feb;108(2):250-1. doi: 10.1111/j.1365-2133.1983.tb00072.x.

引用本文的文献

1
Spotlight on Calcipotriol/Betamethasone Fixed-Dose Combination in Topical Formulations: Is There Still Room for Innovation?聚焦外用制剂中的卡泊三醇/倍他米松固定剂量复方:创新还有空间吗?
Pharmaceutics. 2022 Sep 29;14(10):2085. doi: 10.3390/pharmaceutics14102085.
2
Kinetics of thermal degradation of betamethasone valerate and betamethasone dipropionate in different media.戊酸倍他米松和二丙酸倍他米松在不同介质中的热降解动力学
Indian J Pharm Sci. 2012 Mar;74(2):133-40. doi: 10.4103/0250-474X.103845.
3
Topical formulations of fluocinolone acetonide. Are creams, gels and ointments bioequivalent and does dilution affect activity?
丙酮缩氟氢羟龙的局部用制剂。乳膏、凝胶和软膏是否生物等效,稀释会影响活性吗?
Eur J Clin Pharmacol. 1994;46(1):71-5. doi: 10.1007/BF00195919.